The effects of acute ethanol intake on isoniazid pharmacokinetics
- PMID: 15568141
- DOI: 10.1007/s00228-004-0828-y
The effects of acute ethanol intake on isoniazid pharmacokinetics
Abstract
Aim: To assess effects of acute ethanol intake on the pharmacokinetics of isoniazid in healthy male volunteers.
Methods: Sixteen healthy male, drug-free subjects were studied. Each received in the fasting state, on two occasions separated by at least 1 week, isoniazid (200 mg orally). On one occasion (assigned randomly), subjects received ethanol 0.73 g/kg, 1 h before isoniazid, followed by 0.11 g/kg ethanol orally every hour thereafter for 7 h. Plasma isoniazid and acetylisoniazid concentrations were measured by means of high-performance liquid chromatography. Blood ethanol concentrations were measured hourly by breath analysis. Plasma concentrations of isoniazid and acetylisoniazid were analysed using TOPFIT software.
Results: Peak concentrations of isoniazid were reached within 90 min, in both the ethanol-treated and control groups. The ethanol dosage regimen used resulted in peak blood ethanol concentrations between 78 mg/l and 103 mg/l. There was no significant difference in area under the curve, half-life of elimination or the ratio of acetylisoniazid to isoniazid (AcINH/INH) in the sample withdrawn 3 h after isoniazid dose. Acetylator phenotype for patients was the same in both phases, whether assessed by half-life of isoniazid or the AcINH/INH ratio at 3 h.
Conclusions: Acute ethanol intake at this dose is unlikely to affect results of acetylation studies in which isoniazid is used as a substrate, whether the half-life of isoniazid or the AcINH /INH ratio at 3 h is used to phenotype patients.
Similar articles
-
Unchanged acetylation of isoniazid by alcohol intake.Int J Tuberc Lung Dis. 2004 Nov;8(11):1373-6. Int J Tuberc Lung Dis. 2004. PMID: 15581208 Clinical Trial.
-
Gene dose effect of NAT2 variants on the pharmacokinetics of isoniazid and acetylisoniazid in healthy Chinese subjects.Drug Metabol Drug Interact. 2011;26(3):113-8. doi: 10.1515/DMDI.2011.016. Drug Metabol Drug Interact. 2011. PMID: 21980963
-
Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers.Int J Tuberc Lung Dis. 1999 Jul;3(7):627-31. Int J Tuberc Lung Dis. 1999. PMID: 10423226 Clinical Trial.
-
A single sample saliva test to determine acetylator phenotype.Br J Clin Pharmacol. 1996 Nov;42(5):635-7. doi: 10.1111/j.1365-2125.1996.tb00121.x. Br J Clin Pharmacol. 1996. PMID: 8951197
-
Isoniazid drug and food interactions.Am J Med Sci. 1999 May;317(5):304-11. doi: 10.1097/00000441-199905000-00007. Am J Med Sci. 1999. PMID: 10334118 Review.
Cited by
-
Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).Clin Pharmacokinet. 2014 Dec;53(12):1115-36. doi: 10.1007/s40262-014-0190-x. Clin Pharmacokinet. 2014. PMID: 25267448 Review.
-
Risk assessment of mechanism-based inactivation in drug-drug interactions.Drug Metab Dispos. 2012 Sep;40(9):1653-7. doi: 10.1124/dmd.112.046649. Epub 2012 Jun 8. Drug Metab Dispos. 2012. PMID: 22685217 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources